🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)
China flag China · Delayed Price · Currency is CNY
17.94
+0.01 (0.06%)
Nov 19, 2026, 9:50 AM CST

SHA:600529 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
4,3114,4144,8454,9374,1303,820
Other Revenue
60.0160.0159.5645.6856.8255.53
4,3714,4744,9054,9824,1873,875
Revenue Growth
-1.37%-8.79%-1.55%18.98%8.05%13.08%
Cost of Revenue
3,0603,0883,3393,6183,0902,789
Gross Profit
1,3111,3861,5661,3641,0981,086
Selling, General & Admin
313.99338.72341.62332.17251.59230.19
Research & Development
149.43174.8151.76137.95138.94135.63
Other Operating Expenses
46.843.239.0633.8432.0331.19
Operating Expenses
502.16552.14534.56515.37434.56407.88
Operating Income
808.83833.671,031848.58662.95678.38
Interest Expense
-1.35-0.51-0.03-0.23-0.26-0.28
Interest & Investment Income
29.4433.1135.7744.1116.7417.47
Currency Exchange Gain (Loss)
4.284.2817.2213.0131.5-9.48
Other Non Operating Income (Expenses)
-30.9-3.71-2.36-2.8-0.2-2.44
EBT Excluding Unusual Items
810.31866.841,082902.67710.73683.64
Gain (Loss) on Sale of Investments
12.649.1424.4622.833.739.26
Gain (Loss) on Sale of Assets
-5.4-4.3-1.33-12.24-3.51-22.7
Asset Writedown
-18.83-53.79-5.09-12.88-16.96-11.61
Other Unusual Items
12.6912.9510.7410.4414.0630.13
Pretax Income
811.39830.831,111910.82708.05688.72
Income Tax Expense
143.96141.2167.81135.0289.7697.63
Earnings From Continuing Operations
667.43689.63942.99775.8618.29591.09
Net Income
667.43689.63942.99775.8618.29591.09
Net Income to Common
667.43689.63942.99775.8618.29591.09
Net Income Growth
-12.75%-26.87%21.55%25.48%4.60%4.72%
Shares Outstanding (Basic)
663663664663600597
Shares Outstanding (Diluted)
663663664663600597
Shares Change
-0.15%-0.15%0.15%10.46%0.54%0.49%
EPS (Basic)
1.011.041.421.171.030.99
EPS (Diluted)
1.011.041.421.171.030.99
EPS Growth
-12.62%-26.76%21.37%13.59%4.04%4.21%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
507.04345.06517.27376.45-458.27-58.82
Free Cash Flow Per Share
0.770.520.780.57-0.76-0.10
Dividend Per Share
0.4800.4600.6200.4000.3000.300
Dividend Growth
-20.00%-25.81%55.00%33.33%0%0%
Gross Margin
29.99%30.98%31.93%27.38%26.21%28.03%
Operating Margin
18.50%18.63%21.03%17.03%15.83%17.51%
Profit Margin
15.27%15.41%19.23%15.57%14.77%15.25%
Free Cash Flow Margin
11.60%7.71%10.55%7.56%-10.94%-1.52%
EBITDA
1,2011,2231,4171,174958.13919.03
EBITDA Margin
27.48%27.33%28.88%23.56%22.88%23.71%
D&A For EBITDA
392.34389.26385.15325.13295.17240.64
EBIT
808.83833.671,031848.58662.95678.38
EBIT Margin
18.50%18.63%21.03%17.03%15.83%17.51%
Effective Tax Rate
17.74%16.99%15.11%14.82%12.68%14.17%
Revenue as Reported
4,3714,4744,9054,9824,1873,875